PTPRC and neoplasm: In this study, we performed gene expression profiling of tumors from CRC patients to identify therapy resistance genes and discovered that the expression of protein tyrosine phosphatase receptor type C (PTPRC), which encodes cluster of differentiation 45 (CD45), was increased in remnant tumor tissues after CRT and correlated with metastasis.